Humana Inc.

HUM

$404.80

+1.66%

N/A+$6.60

Healthcare

Medical - Healthcare Plans

NYSE

Active Trading

Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is ...

Recent News of HUM

GuruFocus7/13/2026Somewhat-Bearish (-0.230)

A Look at Humana Inc (HUM) After 3.5% Gain -- GF Value $367.01 vs Price $406.00

Humana Inc (HUM) shares rose 3.5% to $406.00, placing it 10.6% above its GF Value™ of $367.01, suggesting it is modestly overvalued. Despite a strong GF Score™ of 87/100, driven by excellent growth prospects, its financial strength is moderate and its current P/E ratio is significantly higher than its historical median. There has been no insider trading activity in the last three months, which could be interpreted in various ways regarding insider sentiment.

TradingView7/13/2026Somewhat-Bullish (0.170)

Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch

UnitedHealth Group (UNH) is scheduled to report its second-quarter 2026 results on July 16, with earnings estimates currently at $4.84 per share and revenues at $110.05 billion. While the company's stock performance has slightly outperformed the industry year-to-date, its valuation is above its five-year median. The article suggests that despite challenges like regulatory investigations and membership declines, UNH's diversified platform and improved medical cost management are positive factors, advising investors to consider gradual accumulation while monitoring the upcoming earnings.

Yahoo Finance7/13/2026Neutral (0.102)

Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch

UnitedHealth Group (UNH) is preparing to release its second-quarter 2026 earnings, with key estimates predicting an 18.6% increase in earnings per share but a slight decline in revenues. Despite some membership declines and ongoing regulatory scrutiny, the article suggests UNH's diversified platform and medical cost management could drive profitability. While currently trading above its historical valuation, its long-term growth prospects make it an interesting consideration for investors.

TradingView7/13/2026Somewhat-Bullish (0.270)

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana aims for a 3% Medicare Advantage margin by 2028, shifting its focus from membership growth to profitability. The company plans to achieve this through disciplined pricing, improved product design, better retention, and tighter care management, despite current challenges like elevated healthcare utilization. Competitors like UnitedHealth Group and CVS Health also prioritize Medicare Advantage profitability, indicating an industry-wide trend towards margin improvement through similar strategies.

Yahoo Finance7/13/2026Somewhat-Bullish (0.254)

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana (HUM) is targeting a 3% Medicare Advantage margin by 2028, shifting its focus from membership growth to profitability. The company plans to achieve this through disciplined pricing, improved product design, better member retention, and enhanced care management, despite elevated healthcare utilization and regulatory challenges. Peers like UnitedHealth Group (UNH) and CVS Health (CVS) are also implementing similar strategies to restore Medicare Advantage profitability.

GuruFocus•7/13/2026

A Look at Humana Inc (HUM) After 3.5% Gain -- GF Value $367.01 vs Price $406.00

Somewhat-Bearish (-0.230)

financial markets

HUM: Somewhat-Bearish (-0.226)

Relevance 1.000

Humana Inc.

Recent News of HUM

A Look at Humana Inc (HUM) After 3.5% Gain -- GF Value $367.01 vs Price $406.00

Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch

Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

A Look at Humana Inc (HUM) After 3.5% Gain -- GF Value $367.01 vs Price $406.00

Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch

Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Humana pops as Wells Fargo upgrades on moderating cost trends (HUM:NYSE)

CVS Health stock hits 52-week high at 106.16 USD By Investing.com

AMF Tjanstepension AB Has $27.05 Million Stock Position in Humana Inc. $HUM

Bronstein, Gewirtz & Grossman, LLC Is Investigating Humana Inc. (HUM) And Encourages Stockholders to Connect

Sumitomo Mitsui Trust Group Inc. Cuts Stock Holdings in Humana Inc. $HUM

ARGA Investment Management LP Purchases 7,013 Shares of Humana Inc. $HUM

Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth?

Humana Inc. stock outperforms competitors despite losses on the day

The Main Reason Behind Buying UnitedHealth Before July 16

Swedbank AB Has $15.21 Million Stock Position in Humana Inc. $HUM

B. Riley Names Top Digital Health Stock to Buy

Humana (HUM) Stock Looks Fully Priced On Illinois Medicaid Win

Humana Inc. (NYSE:HUM) Receives Consensus Recommendation of "Hold" from Analysts

HCA Healthcare, Inc. (NYSE:HCA) Receives Consensus Rating of "Moderate Buy" from Brokerages

UnitedHealth Stock Leads 3 Policy Sensitive Picks Facing Congress Uncertainty

Alignment Healthcare Shares Fall After Whistleblower Suit Challenges Profit Story

CF Industries Ups Quarterly Dividend 20% to $0.60 a Share, Payable Aug. 31 to Shareholders of Record Aug. 14

UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings?

Gartner (IT) Declines Amid Signs of Slowing Growth

Gartner (IT) Declines Amid Signs of Slowing Growth

Humana Inc outlook and business model as health insurance demand stays robust

UnitedHealth says most home-health diagnoses were supported in 2025

Cantor Fitzgerald raises Humana stock price target on Medicaid data

July 2026 Regulatory & Legislative Update

CMS proposes expanded authority to revoke Medicare privileges

UnitedHealth Group underscores its role in U.S. health coverage as investors watch long term growth

UnitedHealth Group highlights diversified health benefits and services portfolio as investors track long-term growth drivers

CVS Health: The Surprising Healthcare Outlier (NYSE:CVS)

Cantor Fitzgerald reiterates Neutral on Humana stock at $264

Cantor Fitzgerald reiterates Neutral on Humana stock at $264 By Investing.com

Ambetter health plans from Centene Corp. - a key Obamacare product for US families

Humana Stock And 2 More Large Caps Tied To Medicare And Interest Rates

Humana Inc. (HUM) Stock Analysis: Navigating Market Dynamics with a 23.50% Revenue Growth in Healthcare Plans

Molina Healthcare outlines its managed care strategy as a US Medicaid specialist

Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”

Here are Deutsche Bank’s top investment ideas for the third quarter of 2026

HUM - Humana Inc Latest SEC Filings

CVS Health Corp. highlights evolving role in U.S. healthcare. Investors weigh integrated care strategy

Strs Ohio Has $55.25 Million Stock Position in CVS Health Corporation $CVS

Fideuram Intesa Sanpaolo Private Banking S.P.A. Acquires 32,077 Shares of CVS Health Corporation $CVS

Bronstein, Gewirtz & Grossman, LLC Is Investigating Humana Inc. (HUM) And Encourages Shareholders to Connect

Humana (HUM) director Hilzinger granted 233 RSUs, holds 19,448 shares

Humana Inc (HUM) Stock Down 3.1% but Still Overvalued -- GF Scor

Elevance Health sues over Medicare Advantage star ratings

Humana Inc. stock underperforms Thursday when compared to competitors